The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: Results of a phase I exposure escalation study.
 
Lemonitsa H. Mammatas
No Relationships to Disclose
 
Anthe S. Zandvliet
No Relationships to Disclose
 
Maria Rovithi
No Relationships to Disclose
 
Richard J. Honeywell
No Relationships to Disclose
 
Eleonora L. Swart
Employment - Pfizer (I)
Consulting or Advisory Role - Vifor Pharma
Research Funding - Novartis (Inst)
 
Godefridus J. Peters
No Relationships to Disclose
 
Catharina Wilhelmina Menke
Research Funding - Cristal Therapeutics (Inst)
 
Henk M.W. Verheul
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Vitromics (Inst)